<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="55512">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02148432</url>
  </required_header>
  <id_info>
    <org_study_id>4-2014-0232</org_study_id>
    <nct_id>NCT02148432</nct_id>
  </id_info>
  <brief_title>Establishment of Ideal IV Sedative Regimen for Successful Fiberoptic Bronchoscopy in Assessing the Site, Severity of Sleep Apnea Syndrome</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yonsei University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yonsei University</source>
  <oversight_info>
    <authority>Korea: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Venous thromboembolism(VTE) is the third most common cardiovascular complication among
      hospitalized patients, and can even cause death. VTE often occurs in intensive care patients
      and there had been many efforts to prevent such complication. The American College of Chest
      Physicians (ACCP) had published evidence-based clinical practice guideline for VTE
      prophylaxis.

      This study focuses on how VTE prophylaxis is being performed in both medical and surgical
      ICUs in a single University hospital, and sees the differences in such prophylactic
      patterns.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2014</start_date>
  <completion_date type="Anticipated">January 2016</completion_date>
  <primary_completion_date type="Anticipated">January 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator)</study_design>
  <primary_outcome>
    <measure>OAA/S score (Observer's Assessment of Alertness/Sedation Score)</measure>
    <time_frame>5 mins after drug administration</time_frame>
    <safety_issue>No</safety_issue>
    <description>Assessing the degree of patient's alertness, sedation after each drug administration, for the possibility of fiberoptic bronchoscopy examination</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Sleep Apnea Syndrome</condition>
  <arm_group>
    <arm_group_label>dexmedetomidine 0.5 mcg/kg/hr</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>dexmedetomidine 1.0 mcg/kg/hr</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>dexmedetomidine infusion rate, 0.5 mcg/kg/hr</intervention_name>
    <description>continuous infusion of dexmedetomidine at rate of 0.5 mcg/kg/hr</description>
    <arm_group_label>dexmedetomidine 0.5 mcg/kg/hr</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>dexmedetomidine infusion rate, 1.0 mcg/kg/hr</intervention_name>
    <description>continuous infusion of dexmedetomidine at rate of 1.0 mcg/kg/hr</description>
    <arm_group_label>dexmedetomidine 1.0 mcg/kg/hr</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. 20-60 years old patients with ASA class I-II

          2. Scheduled for drug induced sleep endoscope after diagnosed with sleep apnea syndrome

        Exclusion Criteria:

          1. Patients having hearing difficulties, taking any CNS related medication, history of
             any adverse drug reaction, Glasgow coma scale &lt; 15

          2. Patients with severe cardiopulmonary dysfunction

          3. Patients refusal
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Bon Nyeo Koo, MD</last_name>
    <phone>02-2227-3835</phone>
    <email>koobn@yuhs.ac</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Anesthesiology and Pain Medicine, Severance Hospital, Yonsei University College of Medicine</name>
      <address>
        <city>Seoul</city>
        <zip>120-752</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bon Nyeo Koo, MD</last_name>
      <phone>02-2227-3835,</phone>
      <email>koobn@yuhs.ac</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 27, 2014</lastchanged_date>
  <firstreceived_date>May 22, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>sleep apnea syndrome, fiberoptic bronchoscopy, IV sedation</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Dexmedetomidine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
